People: Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

84.60EUR
24 Oct 2014
Price Change (% chg)

€-0.30 (-0.35%)
Prev Close
€84.90
Open
€84.60
Day's High
€84.89
Day's Low
€84.02
Volume
2,561,457
Avg. Vol
3,148,961
52-wk High
€89.95
52-wk Low
€68.29

Search Stocks

Viehbacher, Christopher 

Brief Biography

Mr. Christopher A. Viehbacher has been Chief Executive Officer, Chairman of the Executive Committee and Global Leadership Team and Director of Sanofi SA as of December 1, 2008. He is also Member of the Company's Strategy Committee and has been President of Genzyme as of April 2011. In addition to that, he has been Chair of the CEO Roundtable on Cancer since February 2011. He also holds other mandates, including Vice Chairman of EFPIA (Belgium) and Member of the International Business Council, World Economic Forum (Switzerland), among others. From December 2010 to 2012, Mr. Viehbacher was Chairman of PhRMA in the United States. After starting his career at PriceWaterhouseCoopers, he spent the major part of his professional life (1988-2008) in the Wellcome group, GlaxoWellcome and then GlaxoSmithKline (GSK) where he held different positions across Europe (Germany, France, and Great Britain) and in the United States and Canada. In its last position, Mr. Viehbacher was President, Pharmaceutical Operations North America, Co-Chairman of the Portfolio Management Board. He was made a knight of the French Legion of Honor in 2003. Mr. Viehbacher obtained a Bachelor of Arts degree in Commerce from the Queens University of Ottawa (Canada) and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, EUR Long-Term Incentive Plans, EUR All Other, EUR Fiscal Year Total, EUR
3,528,000 -- -- 3,528,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks